Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neurofibromatoses × diphenylcyclopropenone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Neurofibromatoses 1 Neoplasm Metastasis 1 Melanoma 1 Cutaneous Metastases 1

Interventions

Surveys and Questionnaires 2 talimogene laherparepvec 1 pirfenidone 1 nilotinib 1 mirdametinib 1 diphenylcyclopropenone 1 cabozantinib 1 binimetinib 1 Sunitinib 1 Sirolimus 1 Sevoflurane 1 Propofol 1 Percutaneous Collagen Induction 1 Nitrous Oxide 1 Lidocaine 1 Lasers, Solid-State 1 Lasers 1 Imatinib Mesylate 1 Glycopyrrolate 1 Dexmedetomidine 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05438290 2024-05-06

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Icahn School of Medicine at Mount Sinai

Phase 1 Completed

Neurofibromatosis 1, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon ⚡